ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $1.67M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
3
Closed
–
Calls
$149K
Puts
$487K
Net Calls
-$338K
Net Calls Change
-$590K
Top Buyers
1 |
VF
Virtu Financial
New York
|
$835K |
2 |
Jane Street
New York
|
$476K |
3 |
Morgan Stanley
New York
|
$14K |
4 |
![]()
Simplex Trading
Chicago,
Illinois
|
$8K |
Top Sellers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$319K |
2 |
UBS Group
Zurich,
Switzerland
|
$3K |
3 |
CG
Cutler Group
San Francisco,
California
|
$10K |